Evidence map›Paper›PMID 25642326›Full record

ArticleRSC advances2015

Alginate-peptide amphiphile core-shell microparticles as a targeted drug delivery system.

Job Boekhoven, R Helen Zha, Faifan Tantakitti, Ellen Zhuang, Roya Zandi, Christina J Newcomb, Samuel I Stupp

Abstract read
In one paragraph

Article in RSC advances, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Multicomponent peptide assemblies.Chemical Society reviews · 2018
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Job BoekhovenSimpson Querrey Institute for BioNanotechnology, 303 E. Superior Ave, Chicago, IL 60611 ; Department of Chemistry, Department of Biomedical Engineering and Department of Chemical Engineering, Northwestern University, Tech Building, 2145 Sheridan Road, Evanston, IL 60208.
R Helen ZhaSimpson Querrey Institute for BioNanotechnology, 303 E. Superior Ave, Chicago, IL 60611.
Faifan TantakittiSimpson Querrey Institute for BioNanotechnology, 303 E. Superior Ave, Chicago, IL 60611 ; Department of Chemistry, Department of Biomedical Engineering and Department of Chemical Engineering, Northwestern University, Tech Building, 2145 Sheridan Road, Evanston, IL 60208.
Ellen ZhuangDepartment of Chemistry, Department of Biomedical Engineering and Department of Chemical Engineering, Northwestern University, Tech Building, 2145 Sheridan Road, Evanston, IL 60208.
Roya ZandiDepartment of Chemistry, Department of Biomedical Engineering and Department of Chemical Engineering, Northwestern University, Tech Building, 2145 Sheridan Road, Evanston, IL 60208.
Christina J NewcombSimpson Querrey Institute for BioNanotechnology, 303 E. Superior Ave, Chicago, IL 60611.
Samuel I StuppSimpson Querrey Institute for BioNanotechnology, 303 E. Superior Ave, Chicago, IL 60611 ; Department of Chemistry, Department of Biomedical Engineering and Department of Chemical Engineering, Northwestern University, Tech Building, 2145 Sheridan Road, Evanston, IL 60208 ; Department of Materials Science and Engineering, Northwestern University, Cook Hall, 2220 Campus Drive, Evanston, IL 60208 ; Department of Medicine, Feinberg School of Medicine, Galter Pavilion, 251 E. Huron St., Chicago, IL 60611.

Funding

Regenerative Scaffold Technologies for CNS and DiabetesR01EB003806 · NIBIB · NORTHWESTERN UNIVERSITY AT CHICAGO · PI STUPP, SAMUEL I · 2004 to 2015
$10.7M
NIBIB NIH HHS R01 EB003806
6 · The paper itself

Abstract

We describe in this work the synthesis of microparticles with a doxorubicin drug conjugated alginate core and a shell of peptide amphiphile nanofibres functionalized for targeting the folate receptor. The spherical geometry of the particle core allows high drug loading per surface area, whereas the nanoscale fibrous shell formed by self-assembly of peptide amphiphiles offers a high surface to volume ratio that is ideal for targeting. The synthesised microparticles have a 60-fold higher cytotoxicity against MDA-MB-231 breast cancer cells compared to non-targeting particles.

Identifiers

PMID25642326
PMCPMC4308987

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.